|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Depressive symptoms were assessed with the Symptom Checklist-25 (SCL-25) on both occasions.
|
31846899 |
2020 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
The overall psychopathological burden, as measured by the SCL-90 Global Severity Index (GSI), significantly decreased during the study period (Z = -2.689; p = 0.007), with a relevant improvement with regards to depressive symptoms, anhedonia, and anxiety.
|
31543838 |
2019 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
A device for self-monitoring of the mood state (MoMo) and validated scales such as the Profile of Mood States questionnaire (POMS), the Self-Report Symptom Inventory-Revised (SCL-90-R) and the Hamilton Depression Rating Scale (HDRS) were used to evaluate depressive symptoms.
|
30423466 |
2019 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
We used voxel-based morphometry on a multicenter data set of 409 healthy nonclinical subjects to test the hypothesis that local hippocampal volume would be inversely correlated with subclinical depressive symptoms [Symptom Checklist 90-Revised (SCL-90-R) depression scores].
|
31354542 |
2019 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
The co-primary outcome measures were BMI and 20-item Depression Symptom Checklist (SCL-20) scores (range, 0 [best] to 4 [worst]) at 12 months.
|
30835308 |
2019 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Course of depression symptoms between 3 and 8 months after delivery using two screening tools (EPDS and HSCL-10) on a sample of Sudanese women in Khartoum state.
|
30089466 |
2018 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
When looking at the total population, there was a significant correlation between TNF-α and both the HADS depressive symptoms and the SCL-90-R cluster somatisation.
|
30063870 |
2018 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Severity of mental distress and symptoms of depression were measured with the Symptom Checklist-90-Revised (SCL-90-R) and the Beck Depression Inventory (BDI), respectively.
|
30142462 |
2018 |
|
Depressive Symptoms
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Secondary outcomes include depression symptoms (BDI-II) after 15 months, anxiety symptoms (Beck's Anxiety Inventory (BAI)), level of functioning (Global Assessment of Function (GAF)) and psychological stress (Symptom Checklist-90-Revised (SCL-90-R)).
|
28732523 |
2017 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Severity of depression symptoms at baseline (subscale of the SCL-90-R questionnaire) significantly predicted membership of classes 2 and 3 vs class 1.
|
27787619 |
2017 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
104 participants [27 seronegative (SN)-non-Smokers, 26 SN-Smokers, 29 HIV+ non-Smokers, 22 HIV+ Smokers] were assessed for psychopathology symptoms (Symptom Checklist-90, SCL-90), depressive symptoms (Center for Epidemiologic Studies-Depression Scale, CES-D), impulsivity (Barratt Impulsiveness Scale, BIS), decision-making (The Iowa Gambling Task, IGT, and Wisconsin Card Sorting Test, WCST), and cognition (seven neurocognitive domains).
|
28303534 |
2017 |
|
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Episodic memory was significantly associated with follow-up SCL-90 depressive symptoms.
|
19133876 |
2009 |
|
Depressive Symptoms
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Anxiety and depression symptom scores from the SCL-90 questionnaire were observed in a large sample of nuclear families, and the effects of genes or family environment were estimated.
|
1827639 |
1991 |